Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent

Author： Amadori S. Fenaux P. Ludwig H. O'Dwyer M. Sanz M.

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.21, Iss.3, 2005-03, pp. : 403-412

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Emerging Role of Arsenic Trioxide as an Immunomodulatory Agent in the Management of Multiple Myeloma

Acta Haematologica, Vol. 116, Iss. 1, 2006-07 ,pp. : 1-7

Karger

Access to resources Recommend Favorite

Cefepime-induced encephalopathy in patients with haematological malignancies: Clinical features and risk factors

By Ugai Tomotaka Morisaki Kurimi Tsuda Kenji Sugihara Hiroyuki Nishida Yuhki Yamakura Masayuki Takeuchi Masami Matsue Kosei

Scandinavian Journal of Infectious Diseases, Vol. 46, Iss. 4, 2014-04 ,pp. : 272-279

Informa Healthcare

Access to resources Recommend Favorite

Adding Selenium to Chemotherapy and Radiation in Haematological Malignancies: Clinical Trials Are Justified

Acta Haematologica, Vol. 132, Iss. 2, 2014-06 ,pp. : 254-255

Karger

Access to resources Recommend Favorite

Randomized clinical control study of locoregional therapy combined with arsenic trioxide for the treatment of hepatocellular carcinoma

CANCER, Vol. 121, Iss. 17, 2015-09 ,pp. : 2917-2925

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical experience of granulocyte transfusion in the management of neutropenic patients with haematological malignancies and severe infection

By Cherif Honar Axdorph Ulla Kalin Mats Björkholm Magnus

Scandinavian Journal of Infectious Diseases, Vol. 45, Iss. 2, 2013-02 ,pp. : 112-116

Informa Healthcare

Access to resources Recommend Favorite